| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: what is described a new compound representing (2R)-5'-[5-(morpholin-4-ylmethyl)-3-furyl]-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine and a pharmaceutical composition binding with alpha-7 nicotinic receptors and containing them which can find application in medicine. ^ EFFECT: preparing the new pharmaceutical composition. ^ 2 cl, 16 ex |
